Suppr超能文献

一种用于定量内源性小分子神经生物标志物N-乙酰天门冬氨酸(NAA)的多基质亲水作用色谱-串联质谱法。

A multi-matrix HILIC-MS/MS method for the quantitation of endogenous small molecule neurological biomarker N-acetyl aspartic acid (NAA).

作者信息

Sangaraju Dewakar, Shahidi-Latham Sheerin K, Burgess Braydon L, Dean Brian, Ding Xiao

机构信息

Genentech, Drug Metabolism and Pharmacokinetics, 1 DNA Way, South San Francisco, CA 94080, United States.

Genentech, Drug Metabolism and Pharmacokinetics, 1 DNA Way, South San Francisco, CA 94080, United States.

出版信息

J Pharm Biomed Anal. 2017 Jun 5;140:11-19. doi: 10.1016/j.jpba.2017.03.020. Epub 2017 Mar 14.

Abstract

A multi-matrix hydrophilic interaction liquid chromatography tandem mass spectrometric method (HILIC-MS/MS) was developed for the quantitation of N-Acetyl Aspartic acid (NAA) using stable isotope labeled internal standard, D3-NAA in various biological matrices such as human plasma, human CSF, mouse plasma, brain and spinal cord. A high throughput 96-well plate format supported liquid extraction (SLE) procedure was developed and used for sample preparation. Mass spectrometric analysis of NAA was performed using selected reaction monitoring transitions in positive electrospray ionization mode. As NAA is endogenously present, a surrogate matrix approach was used for quantitation of NAA and the method was qualified over linear calibration curve range of 0.01-10μg/mL. Intra and inter assay precision indicated by percent relative standard deviation (%RSD) was less than 7.1% for low, medium, medium high and high QCs. The accuracy of the method ranged from 92.6-107.0% of nominal concentration for within-run and between-run for the same QCs. Extraction recovery of NAA and D3-NAA was greater than 76%. Stability of NAA was established in the above biological matrices under bench top (RT, 5h), freeze thaw (-20±10°C, 3 cycles) and moues/human plasma sample collection (Wet ice, RT) conditions. HILIC-MS/MS method was then used to quantify and compare the NAA levels in human plasma and CSF of ALS patients versus control human subjects. NAA CSF levels in control human subjects (73.3±31.0ng/mL,N=10) were found to be slightly higher than ALS patients (46.1±22.6ng/mL, N=10) (P=0.04). No differences were observed in NAA plasma levels in human control subjects (49.7±13.8ng/mL,N=9) as compared to ALS patients (49.6±8.1ng/mL, N=10) (P=0.983). NAA endogenous concentrations in mouse plasma, brain and spinal cord were found to be 243.8±56.8ng/mL (N=6), 1029.8±115.2μg/g tissue weight (N=5) and 487.6±178.4μg/g tissue weight (N=5) respectively.

摘要

建立了一种多基质亲水相互作用液相色谱串联质谱法(HILIC-MS/MS),用于使用稳定同位素标记的内标D3-NAA定量测定人血浆、人脑脊液、小鼠血浆、脑和脊髓等各种生物基质中的N-乙酰天门冬氨酸(NAA)。开发了一种高通量96孔板形式的支持液液萃取(SLE)程序并用于样品制备。使用正电喷雾电离模式下的选择反应监测跃迁对NAA进行质谱分析。由于NAA是内源性存在的,因此采用替代基质方法对NAA进行定量,该方法在0.01-μg/mL的线性校准曲线范围内得到验证。低、中、中高和高浓度质量控制样品的批内和批间精密度以相对标准偏差百分比(%RSD)表示,均小于7.1%。该方法的准确度在相同质量控制样品的批内和批间测定中,为标称浓度的92.6-107.0%。NAA和D3-NAA的萃取回收率大于76%。在台式(室温,5小时)、冻融(-20±10°C,3个循环)和小鼠/人血浆样品采集(湿冰,室温)条件下,确定了NAA在上述生物基质中的稳定性。然后使用HILIC-MS/MS方法对肌萎缩侧索硬化症(ALS)患者与对照人类受试者的人血浆和脑脊液中的NAA水平进行定量和比较。发现对照人类受试者的NAA脑脊液水平(73.3±31.0ng/mL,N=10)略高于ALS患者(46.1±22.6ng/mL,N=10)(P=0.04)。与ALS患者(49.6±8.1ng/mL,N=10)相比,人类对照受试者的NAA血浆水平(49.7±13.8ng/mL,N=9)未观察到差异(P=0.983)。发现小鼠血浆、脑和脊髓中的NAA内源性浓度分别为243.8±56.8ng/mL(N=6)、1029.8±115.2μg/g组织重量(N=5)和487.6±178.4μg/g组织重量(N=5)。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验